Table 5.
MRI Evaluation (Cross-Sectional Area and Tunnel Dimensions) - Missing/Contaminated Graft Subjects Included (LOCF)
| 1 Week | 12 Months | 24 Months | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Allo | Xeno | p-value | Allo | Xeno | p-value | Allo | Xeno | p-value | |||
| CSAmax | 74.1 ± 28.6 | 69.1 ± 24.6 | 0.459 | 106.9 ± 49.9 | 120.9 ± 66.9 | 0.447 | 92.0 ± 32.9 | 112.3 ± 51.1 | 0.044* | ||
| FT–AP | 10.2 ± 1.3 | 10.0 ± 0.9 | 0.606 | 9.6 ± 1.7 | 13.6 ± 2.3 | < 0.001** | 10.2 ± 2.2 | 11.9 ± 2.5 | 0.085 | ||
| FT–ML | 10.0 ± 1.2 | 9.3 ± 0.7 | 0.067 | 11.2 ± 2.3 | 14.5 ± 3.2 | 0.004* | 9.6 ± 2.0 | 13.0 ± 1.9 | < 0.001** | ||
| TT–AP | 9.7 ± 1.6 | 9.0 ± 2.0 | 0.053 | 10.3 ± 2.7 | 12.6 ± 2.5 | < 0.001** | 11.4 ± 2.5 | 13.3 ± 2.1 | 0.009* | ||
| TT–ML | 9.4 ± 1.6 | 9.7 ± 1.7 | 0.408 | 10.3 ± 2.1 | 13.0 ± 2.5 | < 0.001** | 10.1 ± 2.0 | 12.1 ± 1.7 | < 0.001** | ||